Tatva Chintan Pharma Chem Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 9, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	25,628	15,840	25,231	36,995	51,166	-
Market Cap Growth	47.35%	-37.22%	-31.80%	-27.70%	-	-
Enterprise Value	26,287	15,844	24,403	37,505	50,113	-
Last Close Price	1095.60	676.48	1075.32	1661.94	2296.74	-
PE Ratio	78.16	277.26	83.12	81.33	53.37	-
Forward PE	41.76	41.06	29.94	36.07	42.29	-
PS Ratio	5.34	4.14	6.41	8.73	11.80	-
PB Ratio	3.40	2.14	3.42	7.19	10.82	-
P/TBV Ratio	3.43	2.16	3.44	7.19	10.82	-
P/OCF Ratio	-	64.21	25.73	133.16	252.92	-
EV/Sales Ratio	5.48	4.14	6.20	8.85	11.56	-
EV/EBITDA Ratio	39.14	47.71	35.40	55.46	46.26	-
EV/EBIT Ratio	66.77	237.11	55.74	64.15	49.87	-
Debt / Equity Ratio	0.11	0.05	0.02	0.33	0.25	0.54
Debt / EBITDA Ratio	1.24	1.09	0.21	2.51	1.10	1.35
Net Debt / Equity Ratio	0.09	0.03	-0.04	0.25	0.12	0.51
Net Debt / EBITDA Ratio	0.98	0.74	-0.45	1.91	0.52	1.27
Net Debt / FCF Ratio	-	-0.48	1.03	-0.74	-0.81	-66.66
Asset Turnover	-	0.46	0.50	0.60	0.89	1.07
Inventory Turnover	-	1.44	1.16	1.40	1.67	2.32
Quick Ratio	-	1.07	1.48	0.54	0.73	0.84
Current Ratio	-	2.76	3.74	1.31	2.55	1.56
Return on Equity (ROE)	-	0.77%	4.85%	9.21%	30.00%	36.85%
Return on Assets (ROA)	-	0.51%	3.47%	5.16%	12.91%	13.34%
Return on Invested Capital (ROIC)	3.71%	0.69%	4.52%	9.97%	23.72%	23.21%
Return on Capital Employed (ROCE)	-	0.90%	5.90%	11.20%	20.60%	30.60%
Earnings Yield	1.28%	0.36%	1.20%	1.23%	1.87%	-
FCF Yield	-	-3.26%	-1.21%	-4.74%	-1.35%	-
Dividend Yield	0.09%	0.15%	0.19%	0.12%	0.09%	-
Payout Ratio	-	81.88%	15.41%	9.75%	-	7.69%
Buyback Yield / Dilution	0.19%	-2.20%	-3.27%	-3.10%	-7.03%	-
Total Shareholder Return	0.27%	-2.05%	-3.08%	-2.98%	-6.94%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.